Page 38 - 《中国医疗器械杂志》2025年第6期

Chinese Journal of Medical Instrumentation 2025年 第49卷 第6期

综 合 评 述

[12] TURANA Y, MATSUSHITA N, SALMAN E, et al. Uhealth, 2022, 10(2): e32251.
Physicians' awareness and practice of home blood [24] MAMAS M A, SPERRIN M, WATSON M C, et al. Do
pressure measurement in Indonesia: Asia home blood patients have worse outcomes in heart failure than in
pressure monitoring survey 2020[J]. Universa Medicina, cancer? A primary care-based cohort study with 10-year
2023, 42(2): 182-194. follow-up in Scotland[J]. Eur J Heart Fail, 2017, 19(9):
[13] KARIO K, HARADA N, OKURA A. Digital therapeutics 1095-1104.
in hypertension: evidence and perspectives[J]. [25] BHATNAGAR R, FONAROW G C, HEIDENREICH P
Hypertension, 2022, 79(10): 2148-2158. A, et al. Expenditure on heart failure in the United States:
[14] KARIO K, HARADA N, OKURA A. The first software the medical expenditure panel survey 2009-2018[J].
as medical device of evidence-based hypertension digital JACC-Heart Fail, 2022, 10(8): 571-580.
therapeutics for clinical practice[J]. Hypertens Res, 2022, [26] BRAHMBHATT D H, ROSS H J, O'SULLIVAN M, et
45(12): 1899-1905. al. The effect of using a remote patient management
[15] NEWBY K, TEAH G, COOKE R, et al. Do automated platform in optimizing guideline-directed medical therapy
digital health behaviour change interventions have a in heart failure patients a randomized controlled trial[J].
positive effect on self-efficacy? A systematic review JACC-Heart Fail, 2024, 12(4): 678-690.
andmeta-analysis[J]. Health Psychol Rev, 2021, 15(1): [27] MARIER-TÉTRAULT E, RIBEIRO P, BÉCHARD S, et
140-158. al. Remote patient monitoring and digital therapeutics in
[16] CHEN C Y, LIU A T, ZHANG Z Z P, et al. Digital heart failure: impact on costs and clinical outcomes[J].
therapeutics in hypertension: how to make sustainable Can J Cardiol, 2024, 40(10): S169-S170.
lifestyle changes[J]. J Clin Hypertens, 2024, 26(10): [28] PICCINELLI E, GRUTTER G, PILATI M, et al. Use of
1125-1132. the CardioMEMS device in children and patients with
[17] CARVALHO M, DUNNE P, KWASNICKA D, et al. congenital heart disease: a literature review[J]. J Clin
Barriers and enablers to maintaining self-management Med, 2024, 13(14): 4234.
behaviours after attending a self-management support [29] CODINA P, VICENTE GÓMEZ J Á, HERNÁNDEZ
intervention for type 2 diabetes: a systematic review and GUILLAMET G, et al. Assessing the impact of
qualitative evidence synthesis[J]. Health Psychol Rev, haemodynamic monitoring with CardioMEMS on heart
2024, 18(3): 478-507. failure patients: a cost–benefit analysis[J]. ESC Heart
[18] SAKIMA A, AKAGI Y, AKASAKI Y, et al. Fail, 2024, 11(4): 1955-1962.
Effectiveness of digital health interventions for [30] GIBSON C M, STEINHUBL S, LAKKIREDDY D, et al.
telemedicine/telehealth for managing blood pressure in Does early detection of atrial fibrillation reduce the risk of
adults: a systematic review and Meta-analysis[J]. thromboembolic events? Rationale and design of the
Hypertens Res, 2025(48): 478-491. Heartline study[J]. Am Heart J, 2023, 259: 30-41.
[19] 赵震宇, 李媛, 郭宇轩, 等. 起始联合降脂策略对心内科 [31] YOSEP I, SURYANI S, MEDIANI H S, et al. Digital
门诊“极高危ASCVD”患者疗效及安全性观察：真 therapy: alleviating anxiety and depression in adolescent
实世界的前瞻性队列研究[J]. 中国临床药理学与治疗 students during COVID-19 online learning-a scoping
学, 2024, 29(8): 907-916. review[J]. J Multidiscip Healthc, 2023(16): 1705-1719.
[20] BRAUNWALD E. How to live to 100 before developing [32] BOLPAGNI M, PARDINI S, GABRIELLI S, et al.
clinical coronary artery disease: a suggestion[J]. Eur Human centered design of AI-powered digital
Heart J, 2022, 43(4): 249-250. therapeutics for stress prevention: perspectives from
[21] GARCÍA R V, GARCÍA J E P, NAVAS W D, et al. multi-stakeholders' workshops about the SHIVA
Impact of a virtual lipid clinic on lipid-lowering therapy, solution[J]. Internet Interv, 2024, 38: 100775.
LDL cholesterol levels, and outcomes in patients with [33] NOMURA A. Digital therapeutics in Japan: present and
acute coronary syndrome[J]. J Clin Lipidol, 2022, 16(5): future directions[J]. J Cardiol, 2025, 85(5): 360-365.
635-642. [34] SCHWARTZ D G, SPITZER S, KHALEMSKY M, et al.
[22] 马双良, 张俊彦, 杨娅梅, 等. 数字疗法在心血管疾病中 Apps don't work for patients who don't use them: towards
的临床研究进展[J]. 心血管病学进展, 2025, 46(4): 294- frameworks for digital therapeutics adherence[J]. Health
297, 309. Policy Techn, 2024, 13(2): 100848.
[23] LI Y X, GONG Y J, ZHENG B, et al. Effects on [35] SESTINO A, D'ANGELO A. Elderly patients' reactions
adherence to a mobile App-based self-management digital to gamification-based digital therapeutics (DTx): the
therapeutics among patients with coronary heart disease: relevance of socialization tendency seeking[J]. Technol
pilot randomized controlled trial[J]. JMIR Mhealth Forecast Soc, 2024(205): 123526.

624